494 related articles for article (PubMed ID: 7733661)
1. Oxidative cleavage of esters and amides to carbonyl products by cytochrome P450.
Peng HM; Raner GM; Vaz AD; Coon MJ
Arch Biochem Biophys; 1995 Apr; 318(2):333-9. PubMed ID: 7733661
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of all-trans, 9-cis, and 13-cis isomers of retinal by purified isozymes of microsomal cytochrome P450 and mechanism-based inhibition of retinoid oxidation by citral.
Raner GM; Vaz AD; Coon MJ
Mol Pharmacol; 1996 Mar; 49(3):515-22. PubMed ID: 8643091
[TBL] [Abstract][Full Text] [Related]
3. Subcellular localization, aggregation state, and catalytic activity of microsomal P450 cytochromes modified in the NH2-terminal region and expressed in Escherichia coli.
Pernecky SJ; Olken NM; Bestervelt LL; Coon MJ
Arch Biochem Biophys; 1995 Apr; 318(2):446-56. PubMed ID: 7733676
[TBL] [Abstract][Full Text] [Related]
4. Microsomal cytochrome P450 dependent oxidation of N-hydroxyguanidines, amidoximes, and ketoximes: mechanism of the oxidative cleavage of their C=N(OH) bond with formation of nitrogen oxides.
Jousserandot A; Boucher JL; Henry Y; Niklaus B; Clement B; Mansuy D
Biochemistry; 1998 Dec; 37(49):17179-91. PubMed ID: 9860831
[TBL] [Abstract][Full Text] [Related]
5. The NH2-terminal region of rabbit CYP2E1 is not essential for interaction with NADPH-cytochrome P450 reductase.
Voznesensky AI; Schenkman JB; Pernecky SJ; Coon MJ
Biochem Biophys Res Commun; 1994 Aug; 203(1):156-61. PubMed ID: 8074649
[TBL] [Abstract][Full Text] [Related]
6. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
[TBL] [Abstract][Full Text] [Related]
7. Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
Köster U; Speerschneider P; Kerssebaum R; Wittmann H; Dekant W
Drug Metab Dispos; 1994; 22(5):667-72. PubMed ID: 7835215
[TBL] [Abstract][Full Text] [Related]
8. Mechanism-based inactivation of cytochrome P450 2B4 by aldehydes: relationship to aldehyde deformylation via a peroxyhemiacetal intermediate.
Raner GM; Chiang EW; Vaz AD; Coon MJ
Biochemistry; 1997 Apr; 36(16):4895-902. PubMed ID: 9125510
[TBL] [Abstract][Full Text] [Related]
9. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
[TBL] [Abstract][Full Text] [Related]
10. Interactions among P450 enzymes when combined in reconstituted systems: formation of a 2B4-1A2 complex with a high affinity for NADPH-cytochrome P450 reductase.
Backes WL; Batie CJ; Cawley GF
Biochemistry; 1998 Sep; 37(37):12852-9. PubMed ID: 9737863
[TBL] [Abstract][Full Text] [Related]
11. Oxidation of tolualdehydes to toluic acids catalyzed by cytochrome P450-dependent aldehyde oxygenase in the mouse liver.
Watanabe K; Matsunaga T; Yamamoto I; Yashimura H
Drug Metab Dispos; 1995 Feb; 23(2):261-5. PubMed ID: 7736922
[TBL] [Abstract][Full Text] [Related]
12. Aromatization of a bicyclic steroid analog, 3-oxodecalin-4-ene-10-carboxaldehyde, by liver microsomal cytochrome P450 2B4.
Vaz AD; Kessell KJ; Coon MJ
Biochemistry; 1994 Nov; 33(46):13651-61. PubMed ID: 7947773
[TBL] [Abstract][Full Text] [Related]
13. Baculovirus expression of human P450 2E1 and cytochrome b5: spectral and catalytic properties and effect of b5 on the stoichiometry of P450 2E1-catalyzed reactions.
Patten CJ; Koch P
Arch Biochem Biophys; 1995 Mar; 317(2):504-13. PubMed ID: 7893169
[TBL] [Abstract][Full Text] [Related]
14. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
[TBL] [Abstract][Full Text] [Related]
15. Microsomal ethanol oxidizing system activity by human hepatic cytochrome P450s.
Asai H; Imaoka S; Kuroki T; Monna T; Funae Y
J Pharmacol Exp Ther; 1996 May; 277(2):1004-9. PubMed ID: 8627510
[TBL] [Abstract][Full Text] [Related]
16. Redox cycling in the metabolism of the environmental pollutant and suspected human carcinogen o-anisidine by rat and rabbit hepatic microsomes.
Naiman K; Dracínská H; Martínková M; Sulc M; Dracínský M; Kejíková L; Hodek P; Hudecek J; Liberda J; Schmeiser HH; Frei E; Stiborová M
Chem Res Toxicol; 2008 Aug; 21(8):1610-21. PubMed ID: 18624415
[TBL] [Abstract][Full Text] [Related]
17. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
Dong MS; Yamazaki H; Guo Z; Guengerich FP
Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli.
Dong J; Porter TD
Arch Biochem Biophys; 1996 Mar; 327(2):254-9. PubMed ID: 8619611
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of ethanol-inducible cytochrome P450 and other microsomal P450 isozymes by trans-4-hydroxy-2-nonenal, a major product of membrane lipid peroxidation.
Bestervelt LL; Vaz AD; Coon MJ
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3764-8. PubMed ID: 7731980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]